{"id":1495,"date":"2025-09-02T20:49:36","date_gmt":"2025-09-02T20:49:36","guid":{"rendered":"https:\/\/finzexpert.com\/blog\/stocks-making-the-biggest-moves-midday-ulcc-khc-pep-biib\/"},"modified":"2025-09-02T20:49:36","modified_gmt":"2025-09-02T20:49:36","slug":"stocks-making-the-biggest-moves-midday-ulcc-khc-pep-biib","status":"publish","type":"post","link":"https:\/\/finzexpert.com\/blog\/stocks-making-the-biggest-moves-midday-ulcc-khc-pep-biib\/","title":{"rendered":"Stocks making the biggest moves midday : ULCC, KHC, PEP, BIIB"},"content":{"rendered":"\n<div>\n<div data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<p><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">Check out the companies making the biggest moves in midday trading: Frontier Group \u2014 Shares of the budget airline carrier shot up more than 13% in the wake of rival Spirit Airlines&#8217; bankruptcy filing on Friday. Humana \u2014 Shares of the health insurer rose more than 2% after the company reaffirmed on Friday its fiscal 2025 earnings forecast. Humana expects to earn about $17 per share after adjustments. Following the announcement, Bank of America raised its price target, but reiterated its neutral stance on the stock United Therapeutics \u2014 The biotech soared 35% after saying its TETON-2 study evaluating the use of nebulized Tyvaso (treprostinil) Inhalation Solution to treat idiopathic pulmonary fibrosis met its primary efficacy endpoint . Ionis Pharmaceuticals \u2014 The maker of RNA-targeted medicines jumped 32% when it said Phase 3 CORE and CORE2 studies of olezarsen in patients with severe hypertriglyceridemia showed &#8221; a highly statistically significant placebo-adjusted mean reduction in fasting triglycerides of up to 72% and a highly statistically significant reduction in acute pancreatitis events of 85% with favorable safety and tolerability.&#8221; PepsiCo \u2014 The snack and beverage giant rose more than 2% after activist investor Elliott Management took a $4 billion stake in the company, touting a &#8220;rare&#8221; and &#8220;historic&#8221; opportunity for a turnaround at the iconic soft drink and snack company. The investment by Elliott, founded by Paul Singer, was first reported by the Wall Street Journal . Elliott, now one of Pepsi&#8217;s five largest active investors, sent a presentation and letter to Pepsi&#8217;s board of directors Tuesday, detailing an agenda for restoring business momentum. Kraft Heinz \u2014 Shares tumbled nearly 7% after the food company confirmed earlier reports that it would split up into two publicly traded companies , which will be nameded at a later date. One unit, which currently goes by &#8220;Global Taste Elevation,&#8221; will include Kraft&#8217;s shelf-stable products such as Heinz and Kraft Mac &amp; Cheese. The other one, &#8220;North American Grocery,&#8221; will include brands such as Oscar Mayer and Lunchables. Constellation Brands \u2014 The stock tumbled 7% after the brewer cut its full-year guidance. It now expects earnings to come in between $10.77 and $11.07 per share, down from its prior guidance of $12.07 and $12.37 per share. Air Lease \u2014 Shares rose more than 6% after the aircraft leasing company reached a merger deal with Apollo, Brookfield, SMBC Aviation Capital and Sumitomo. The deal, which is expected to close in the first half of next year, values the company at about $28.2 billion including debt. Cytokinetics \u2014 The late-stage biopharmaceutical company soared 40% after it said a clinical trial of its heart disease drug, aficamten, showed a meaningful improvement in patients with symptomatic obstructive hypertrophic cardiomyopathy, than the standard of care, metoprolol. Lam Research \u2014 The stock fell 4% following a downgrade at Morgan Stanley to underweight from equal weight. The bank said it doesn&#8217;t expect Lam Research to sustain growth into 2026. Biogen \u2014 The biopharma stock added almost 4% after Biogen and Eisai&#8217;s said the Food and Drug Administration approved an injectable version of their Alzheimer&#8217;s disease drug, Leqembi. Newmont \u2014 The gold miner gained 2% after the precious metal hit a record high of $3,508.50 earlier in Tuesday&#8217;s session. \u2014CNBC&#8217;s Scott Schnipper, Michelle Fox, Fred Imbert and Alex Harring contributed reporting.<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Check out the companies making the biggest moves in midday trading: Frontier Group \u2014 Shares of the budget airline carrier shot up more than 13% in the wake of rival Spirit Airlines&#8217; bankruptcy filing on Friday. Humana \u2014 Shares of the health insurer rose more than 2% after the company reaffirmed on Friday its fiscal [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1496,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[193,1355,1353,192,195,194,1354,191,1352],"class_list":["post-1495","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-loan","tag-biggest","tag-biib","tag-khc","tag-making","tag-midday","tag-moves","tag-pep","tag-stocks","tag-ulcc"],"_links":{"self":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts\/1495","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/comments?post=1495"}],"version-history":[{"count":0,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts\/1495\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/media\/1496"}],"wp:attachment":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/media?parent=1495"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/categories?post=1495"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/tags?post=1495"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}